Do analysts rate CCM or PIII?

P3 Health Partners has a consensus price target of $14.00, suggesting a potential upside of 45.53%. Given P3 Health Partners' stronger consensus rating and higher probable upside, analysts clearly believe P3 Health Partners is more favorable than Concord Medical Services. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 P3 Health Partners 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings and valuation, CCM or PIII?

Concord Medical Services has higher earnings, but lower revenue than P3 Health Partners. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Concord Medical Services $65.85M 0.28 -$13.27M N/A N/A P3 Health Partners $1.47B 0.05 -$147.95M -$38.60 N/A

Is CCM or PIII more profitable?

Concord Medical Services has a net margin of 0.00% compared to P3 Health Partners' net margin of -8.57%. Company Net Margins Return on Equity Return on Assets Concord Medical Services N/A N/A N/A P3 Health Partners -8.57% N/A -19.99%

Do analysts prefer CCM or NAKA?

KindlyMD has a consensus target price of $30.00, indicating a potential upside of 516.02%. Given KindlyMD's stronger consensus rating and higher possible upside, analysts plainly believe KindlyMD is more favorable than Concord Medical Services. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 KindlyMD 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has higher earnings & valuation, CCM or NAKA?

Concord Medical Services has higher revenue and earnings than KindlyMD. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Concord Medical Services $65.85M 0.28 -$13.27M N/A N/A KindlyMD $1.82M 46.56 -$52.23M -$43.20 N/A

Do analysts recommend DCGO or CCM?

DocGo presently has a consensus target price of $2.38, suggesting a potential upside of 298.62%. Given DocGo's stronger consensus rating and higher probable upside, equities analysts plainly believe DocGo is more favorable than Concord Medical Services. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DocGo 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33 Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, DCGO or CCM?

Concord Medical Services has lower revenue, but higher earnings than DocGo. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DocGo $301.71M 0.20 -$182.40M -$1.91 N/A Concord Medical Services $65.85M 0.28 -$13.27M N/A N/A

Do analysts prefer EUDA or CCM?

EUDA Health currently has a consensus target price of $55.00, suggesting a potential upside of 266.91%. Given EUDA Health's stronger consensus rating and higher possible upside, equities analysts plainly believe EUDA Health is more favorable than Concord Medical Services. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score EUDA Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, EUDA or CCM?

EUDA Health has higher earnings, but lower revenue than Concord Medical Services. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio EUDA Health $6.82M 6.57 -$2.77M N/A N/A Concord Medical Services $65.85M 0.28 -$13.27M N/A N/A

Is EUDA or CCM more profitable?

Company Net Margins Return on Equity Return on Assets EUDA Health N/A N/A N/A Concord Medical Services N/A N/A N/A

Do analysts prefer MRAI or CCM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Marpai 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, MRAI or CCM?

Concord Medical Services has higher revenue and earnings than Marpai. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Marpai $34.87M 1.83 -$28.75M -$0.87 N/A Concord Medical Services $65.85M 0.28 -$13.27M N/A N/A

Is MRAI or CCM more profitable?

Concord Medical Services has a net margin of 0.00% compared to Marpai's net margin of -85.70%. Company Net Margins Return on Equity Return on Assets Marpai -85.70% N/A -100.23% Concord Medical Services N/A N/A N/A

Concord Medical Services (CCM) Competitors

$4.24 +0.02 (+0.47%)

Closing price 07/24/2026 03:59 PM Eastern

Extended Trading

$4.26 +0.01 (+0.35%)

As of 07/24/2026 04:02 PM Eastern

Compare

CCM vs. PIII, NAKA, DCGO, EUDA, and MRAI

Should you buy Concord Medical Services stock or one of its competitors? MarketBeat compares Concord Medical Services with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Concord Medical Services include P3 Health Partners (PIII), KindlyMD (NAKA), DocGo (DCGO), EUDA Health (EUDA), and Marpai (MRAI). These companies are all part of the "healthcare" industry.

How does Concord Medical Services compare to P3 Health Partners?

Concord Medical Services (NYSE:CCM) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.

Concord Medical Services has a net margin of 0.00% compared to P3 Health Partners' net margin of -8.57%.

Company	Net Margins	Return on Equity	Return on Assets
Concord Medical Services	N/A	N/A	N/A
P3 Health Partners	-8.57%	N/A	-19.99%

P3 Health Partners has a consensus price target of $14.00, suggesting a potential upside of 45.53%. Given P3 Health Partners' stronger consensus rating and higher probable upside, analysts clearly believe P3 Health Partners is more favorable than Concord Medical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, P3 Health Partners had 1 more articles in the media than Concord Medical Services. MarketBeat recorded 2 mentions for P3 Health Partners and 1 mentions for Concord Medical Services. Concord Medical Services' average media sentiment score of 1.00 beat P3 Health Partners' score of 0.63 indicating that Concord Medical Services is being referred to more favorably in the media.

Company	Overall Sentiment
Concord Medical Services	Positive
P3 Health Partners	Positive

Concord Medical Services has a beta of -0.97, indicating that its share price is 197% less volatile than the broader market. Comparatively, P3 Health Partners has a beta of 1.62, indicating that its share price is 62% more volatile than the broader market.

7.8% of P3 Health Partners shares are held by institutional investors. 46.5% of Concord Medical Services shares are held by insiders. Comparatively, 10.9% of P3 Health Partners shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Concord Medical Services has higher earnings, but lower revenue than P3 Health Partners.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Concord Medical Services	$65.85M	0.28	-$13.27M	N/A	N/A
P3 Health Partners	$1.47B	0.05	-$147.95M	-$38.60	N/A

Summary

P3 Health Partners beats Concord Medical Services on 7 of the 13 factors compared between the two stocks.

How does Concord Medical Services compare to KindlyMD?

Concord Medical Services (NYSE:CCM) and KindlyMD (NASDAQ:NAKA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

In the previous week, KindlyMD had 1 more articles in the media than Concord Medical Services. MarketBeat recorded 2 mentions for KindlyMD and 1 mentions for Concord Medical Services. KindlyMD's average media sentiment score of 1.31 beat Concord Medical Services' score of 1.00 indicating that KindlyMD is being referred to more favorably in the news media.

Company	Overall Sentiment
Concord Medical Services	Positive
KindlyMD	Positive

Concord Medical Services has a net margin of 0.00% compared to KindlyMD's net margin of -7,397.12%. Concord Medical Services' return on equity of 0.00% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Concord Medical Services	N/A	N/A	N/A
KindlyMD	-7,397.12%	-81.32%	-54.17%

KindlyMD has a consensus target price of $30.00, indicating a potential upside of 516.02%. Given KindlyMD's stronger consensus rating and higher possible upside, analysts plainly believe KindlyMD is more favorable than Concord Medical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Concord Medical Services has higher revenue and earnings than KindlyMD.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Concord Medical Services	$65.85M	0.28	-$13.27M	N/A	N/A
KindlyMD	$1.82M	46.56	-$52.23M	-$43.20	N/A

Concord Medical Services has a beta of -0.97, indicating that its stock price is 197% less volatile than the broader market. Comparatively, KindlyMD has a beta of 16.05, indicating that its stock price is 1,505% more volatile than the broader market.

Summary

KindlyMD beats Concord Medical Services on 7 of the 12 factors compared between the two stocks.

How does Concord Medical Services compare to DocGo?

DocGo (NASDAQ:DCGO) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk.

56.4% of DocGo shares are owned by institutional investors. 5.1% of DocGo shares are owned by company insiders. Comparatively, 46.5% of Concord Medical Services shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

DocGo presently has a consensus target price of $2.38, suggesting a potential upside of 298.62%. Given DocGo's stronger consensus rating and higher probable upside, equities analysts plainly believe DocGo is more favorable than Concord Medical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Concord Medical Services has lower revenue, but higher earnings than DocGo.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$301.71M	0.20	-$182.40M	-$1.91	N/A
Concord Medical Services	$65.85M	0.28	-$13.27M	N/A	N/A

In the previous week, DocGo had 1 more articles in the media than Concord Medical Services. MarketBeat recorded 2 mentions for DocGo and 1 mentions for Concord Medical Services. Concord Medical Services' average media sentiment score of 1.00 beat DocGo's score of 0.94 indicating that Concord Medical Services is being referred to more favorably in the news media.

Company	Overall Sentiment
DocGo	Positive
Concord Medical Services	Positive

Concord Medical Services has a net margin of 0.00% compared to DocGo's net margin of -62.23%. Concord Medical Services' return on equity of 0.00% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DocGo	-62.23%	-44.09%	-29.14%
Concord Medical Services	N/A	N/A	N/A

DocGo has a beta of 1.02, indicating that its stock price is 2% more volatile than the broader market. Comparatively, Concord Medical Services has a beta of -0.97, indicating that its stock price is 197% less volatile than the broader market.

Summary

DocGo and Concord Medical Services tied by winning 7 of the 14 factors compared between the two stocks.

How does Concord Medical Services compare to EUDA Health?

EUDA Health (NASDAQ:EUDA) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, profitability, valuation and earnings.

EUDA Health has higher earnings, but lower revenue than Concord Medical Services.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	6.57	-$2.77M	N/A	N/A
Concord Medical Services	$65.85M	0.28	-$13.27M	N/A	N/A

EUDA Health currently has a consensus target price of $55.00, suggesting a potential upside of 266.91%. Given EUDA Health's stronger consensus rating and higher possible upside, equities analysts plainly believe EUDA Health is more favorable than Concord Medical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

EUDA Health has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market. Comparatively, Concord Medical Services has a beta of -0.97, meaning that its stock price is 197% less volatile than the broader market.

In the previous week, EUDA Health had 1 more articles in the media than Concord Medical Services. MarketBeat recorded 2 mentions for EUDA Health and 1 mentions for Concord Medical Services. Concord Medical Services' average media sentiment score of 1.00 beat EUDA Health's score of 0.93 indicating that Concord Medical Services is being referred to more favorably in the news media.

Company	Overall Sentiment
EUDA Health	Positive
Concord Medical Services	Positive

4.4% of EUDA Health shares are held by institutional investors. 46.5% of Concord Medical Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
Concord Medical Services	N/A	N/A	N/A

Summary

EUDA Health beats Concord Medical Services on 8 of the 11 factors compared between the two stocks.

How does Concord Medical Services compare to Marpai?

Marpai (NASDAQ:MRAI) and Concord Medical Services (NYSE:CCM) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

Marpai has a beta of 4.92, indicating that its stock price is 392% more volatile than the broader market. Comparatively, Concord Medical Services has a beta of -0.97, indicating that its stock price is 197% less volatile than the broader market.

49.8% of Marpai shares are owned by institutional investors. 46.1% of Marpai shares are owned by insiders. Comparatively, 46.5% of Concord Medical Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Concord Medical Services has higher revenue and earnings than Marpai.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Marpai	$34.87M	1.83	-$28.75M	-$0.87	N/A
Concord Medical Services	$65.85M	0.28	-$13.27M	N/A	N/A

In the previous week, Marpai and Marpai both had 1 articles in the media. Concord Medical Services' average media sentiment score of 1.00 beat Marpai's score of 0.00 indicating that Concord Medical Services is being referred to more favorably in the news media.

Company	Overall Sentiment
Marpai	Neutral
Concord Medical Services	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Marpai	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Concord Medical Services has a net margin of 0.00% compared to Marpai's net margin of -85.70%.

Company	Net Margins	Return on Equity	Return on Assets
Marpai	-85.70%	N/A	-100.23%
Concord Medical Services	N/A	N/A	N/A

Summary

Concord Medical Services beats Marpai on 7 of the 10 factors compared between the two stocks.

Get Concord Medical Services News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CCM vs. The Competition

Export

Metric	Concord Medical Services	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$18.32M	$4.18B	$6.87B	$23.46B
Dividend Yield	N/A	0.69%	2.67%	4.20%
P/E Ratio	N/A	14.21	27.11	30.75
Price / Sales	0.28	1.43	511.13	166.63
Price / Cash	2.27	19.86	50.54	31.69
Price / Book	0.07	2.60	10.28	4.73
Net Income	-$13.27M	$47.01M	$3.60B	$1.07B
7 Day Performance	4.69%	1.43%	-1.27%	-0.45%
1 Month Performance	-3.85%	2.75%	-0.37%	0.72%
1 Year Performance	-22.34%	57.18%	18.30%	14.09%

Concord Medical Services Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCM Concord Medical Services	1.3058 of 5 stars	$4.24 +0.5%	N/A	-21.6%	$18.32M	$65.85M	N/A	970	Positive News Short Interest Decrease Gap Down
PIII P3 Health Partners	2.5059 of 5 stars	$10.21 -2.1%	$14.00 +37.1%	+32.1%	$75.57M	$1.46B	N/A	500	Positive News
NAKA KindlyMD	3.8554 of 5 stars	$4.38 +10.1%	$30.00 +584.9%	-98.9%	$69.26M	$1.82M	N/A	N/A	Positive News
DCGO DocGo	3.164 of 5 stars	$0.66 +3.1%	$2.38 +257.3%	-58.9%	$63.67M	$322.20M	N/A	3,568	News Coverage
EUDA EUDA Health	1.556 of 5 stars	$11.68 +4.5%	$55.00 +370.7%	-76.0%	$33.48M	$6.82M	N/A	2	Upcoming Earnings Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CCM) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Concord Medical Services (CCM) Competitors

CCM vs. PIII, NAKA, DCGO, EUDA, and MRAI

How does Concord Medical Services compare to P3 Health Partners?

Summary

How does Concord Medical Services compare to KindlyMD?

Summary

How does Concord Medical Services compare to DocGo?

Summary

How does Concord Medical Services compare to EUDA Health?

Summary

How does Concord Medical Services compare to Marpai?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCM vs. The Competition

Concord Medical Services Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Concord Medical Services (CCM) Competitors

CCM vs. PIII, NAKA, DCGO, EUDA, and MRAI

How does Concord Medical Services compare to P3 Health Partners?

Is CCM or PIII more profitable?

Do analysts rate CCM or PIII?

Does the media prefer CCM or PIII?

Which has more risk and volatility, CCM or PIII?

Do institutionals & insiders believe in CCM or PIII?

Which has better earnings and valuation, CCM or PIII?

Summary

How does Concord Medical Services compare to KindlyMD?

Does the media refer more to CCM or NAKA?

Is CCM or NAKA more profitable?

Do analysts prefer CCM or NAKA?

Which has higher earnings & valuation, CCM or NAKA?

Which has more volatility and risk, CCM or NAKA?

Summary

How does Concord Medical Services compare to DocGo?

Do institutionals & insiders hold more shares of DCGO or CCM?

Do analysts recommend DCGO or CCM?

Which has preferable valuation & earnings, DCGO or CCM?

Does the media favor DCGO or CCM?

Is DCGO or CCM more profitable?

Which has more risk & volatility, DCGO or CCM?

Summary

How does Concord Medical Services compare to EUDA Health?

Which has preferable earnings and valuation, EUDA or CCM?

Do analysts prefer EUDA or CCM?

Which has more volatility and risk, EUDA or CCM?

Does the media prefer EUDA or CCM?

Do insiders and institutionals hold more shares of EUDA or CCM?

Is EUDA or CCM more profitable?

Summary

How does Concord Medical Services compare to Marpai?

Which has more risk & volatility, MRAI or CCM?

Do insiders & institutionals hold more shares of MRAI or CCM?

Which has stronger valuation and earnings, MRAI or CCM?

Does the media favor MRAI or CCM?

Do analysts prefer MRAI or CCM?

Is MRAI or CCM more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCM vs. The Competition

Concord Medical Services Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools